-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Globus Medical, Raises Price Target to $100

Benzinga·12/02/2025 17:38:33
Listen to the news
Morgan Stanley analyst Drew Ranieri maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $70 to $100.